RetaMaps

Radiant Health

Radiant Health · 371 Coffeen Avenue · Sheridan, WY 82801

5.0· 20 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Radiant Health is a functional medicine and aesthetic clinic in Sheridan, Wyoming whose website lists hormone replacement, gut health, weight loss, Botox, PRP facial and hair restoration and IV hydration. The site describes in-house lab evaluation, in-depth consultations and a focus on root causes, and names Colby Butler, FNP-C, and Lauren Sebade, FNP-C. On Google it has a 5.0-star rating across 20 reviews dating back to 2024, with two in the past year; reviewers most often mention the providers' knowledge and feeling cared for.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay acceptedYes
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 20 reviews
2
reviews in the past year (avg ★ 5.0)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-02-23. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 20 Google reviews. Of the 17 reviews we analyzed, 17 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Knowledgeable, professional providers7 reviews
  • Feeling listened to5 reviews
  • Friendly, helpful staff2 reviews
  • Weight-loss results2 reviews

Common complaints

No negative reviews among those we analyzed.

5★
17
4★
0
3★
0
2★
0
1★
0

Most recent Google reviews

Rose★★★★★2026-02-23

they did a good on my friend I’m just shocked of how good they are I would recommend them to all my friends they are a great place to go to for your health needs.

Samantha B.★★★★★2026-02-12

My whole family has seen Colby and Three of us have seen Brandon. We have had the best care from not just them but all of the staff there! They actually care about whats going on with your health and want to help you solve your issues. We are finally getting answers. Highly recommend Them!

Sara S.★★★★★2025-07-29

Colby is amazing! She is so knowledgeable and interested in getting to the root cause of things. So grateful to have found her and Radiant Health!

Teresa S.★★★★★2025-06-11

Colby is unbelievably kind and informative! Hormone changes are hard personally and because I found someone who listens, I feel like myself again.

Morgan H.★★★★★2025-03-11

My experience with Colby was so great! She made me feel very comfortable and my results look amazing!

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Sheridan

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs